Nov 13, 1987 (Vol. 36, No. 44).—ON SEPTEMBER 18, 1987, the Armed Forces Medical Logistical Office issued instructions to temporarily suspend from distribution and use in military hospitals one lot (RHG 636) of RhoGAM* Rho(D) Immune Globulin (human) (Rh-IG), manufactured by Ortho Diagnostic Systems, Inc. This action was taken because a woman on active duty who had received an injection from the lot was subsequently found to be infected with human immunodeficiency virus (HIV). The woman received RhoGAM lot RHG 636 in September 1986, prior to the birth of her second child in December 1986. In addition, she had received an earlier injection of Rh-IG from a different lot in May 1985, prior to the birth of her first child.
The woman was first tested for HIV in November 1986 as part of the military screening program and was found to be seropositive for HIV antibodies at